- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06006000
Evaluating the Unmet Needs of Older Adults to Promote Functional Recovery After a Critical Illness (LANTERN)
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Nicole Bouranis, PhD
- Phone Number: +1 (203) 737-1731
- Email: nicole.bouranis@yale.edu
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Recruiting
- Yale New Haven Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
PARTICIPANTS
- Age ≥ 65 years
- Survived an ICU admission of ≥2 days
CAREGIVERS
- Age ≥ 18 years
- Identified as caregiver of LANTERN participant who is an informal (unpaid) caregiver.
Exclusion Criteria:
PARTICIPANTS
- Advance directive of comfort measures only (CMO) or a transition to hospice
- Planned discharge to a location other than home or Short-Term Rehab
- Tracheostomy with ventilator dependence
- Severe acute or prior neurologic injury (such as anoxic brain injury or acute, massive stroke)
- Advanced dementia
- ICU admission for monitoring only (e.g., antibiotic desensitization)
- Primary language other than English.
CAREGIVERS
- Primary language other than English
- Is a paid caregiver
- Unwilling to complete a qualitative interview
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Older adults returning home post-ICU
Community-dwelling older adults who return home (either directly or after a stay in short-term rehab (STR)) after an ICU hospitalization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Disability Count
Time Frame: monthly up to 6 months
|
Number of instances of disability during activities of daily living (ADLs), instrumental activities of daily living (IADLs), and mobility activity.
Disability is defined as an inability to complete the task or the need for personal assistance to complete the task.
The higher the count, the more disability.
|
monthly up to 6 months
|
Number of hospital readmissions
Time Frame: monthly up to 6 months
|
Number of hospital readmissions monthly up to 6 months.
|
monthly up to 6 months
|
Number of deaths
Time Frame: monthly up to 6 months
|
Number of deaths each month up to 6 months.
|
monthly up to 6 months
|
Barriers and Facilitators to addressing unmet needs
Time Frame: month 6
|
Barriers and facilitators to addressing unmet needs will be assessed using qualitative interviews.
A subgroup of participants will receive qualitative interviews conducted with members of the study team.
Content analysis will then be used to identify barriers and facilitators to addressing unmet needs that will be informative when planning a future intervention.
|
month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional non-recovery
Time Frame: monthly up to 6 months
|
Not returning to the pre-ICU functional baseline within the follow-up period
|
monthly up to 6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lauren Ferrante, MD, MHS, Yale School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2000034943
- 1R01AG079916-01A1 (U.S. NIH Grant/Contract: NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Deidentified data from this study will be available to investigators who sign a Data Use Agreement (DUA) executed between Yale University and the investigator's institution. The DUA requires the investigators to attest to (1) their commitment to using the data only for approved research purposes and not to identify any individual human participant; (2) their commitment to securing the data using appropriate computer technology; and (3) their commitment to destroying or returning the data after analyses are completed.
Data will not be available until all analyses are complete.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Peking Union Medical College HospitalBaxter Healthcare CorporationUnknownNutrition Therapy for Critical Illness
-
Assistance Publique - Hôpitaux de ParisRecruitingCritical Illness Related Corticosteroids InsufficiencyFrance
-
Yuzuncu Yıl UniversityKahramanmaras Sutcu Imam University; Izmir Ataturk Training and Research HospitalCompleted
-
University Hospital Birmingham NHS Foundation TrustCompletedRehabilitation After Critical Illness